Friedel wolf (41 résultats)

Broschiert. Etat : Gut. 132 Seiten Das Buch befindet sich in einem ordentlich erhaltenen Zustand. Leichte altersbedingte Anbräunung des Papiers. In ENGLISCHER Sprache. Sprache: Englisch Gewicht in Gramm: 260.

Softcover. Etat : Wie neu. Ohne Schutzumschlag. 1. Auflage. Im nächsten Jahr kommt Sabine in die Schule. Bis es soweit ist, verlebt sie aufregende Monate: Zum ersten Mal schaut sie sich richtig in der Natur um. Wie früh sich die Schneeglöckchen hervorwagen, und wie prachtvoll später die Apfelbäume blühen! Als sie für Oma im Garten einen Blumenstrauß pflückt, weiß sie noch nicht, dass aus den hübschen weißen Blüten einmal Erdbeeren wachsen sollten. Zum Glück sind noch genügend da, sodass Sabine im Sommer viele süße Beeren ernten kann. Im Herbst sammelt sie mit ihrem Bruder Eicheln und Kastanien. Schließlich verlieren die Bäume ihre Blätter, und der erste Schnee fällt ., 80 Seiten, 1. Auflage 2002.…

Hardcover. Etat : Bon. Couverture différente. Edition 1980. Ammareal reverse jusqu'à 15% du prix net de cet article à des organisations caritatives. ENGLISH DESCRIPTION Book Condition: Used, Good. Different cover. Edition 1980. Ammareal gives back up to 15% of this item's net price to charity organizations.…

Hardback. Etat : New.

15 x 23 cm. 129 pages. Paperback. Versand aus Deutschland / We dispatch from Germany via Air Mail. Einband bestoßen, daher Mängelexemplar gestempelt, sonst sehr guter Zustand. Imperfect copy due to slightly bumped cover, apart from this in very good condition. Stamped. Sprache: Englisch.

Gebundene Ausgabe. Etat : Gut. 112 Seiten Ausgabe von 1980, ausgesondertes BÃchereibuch 2480 Sprache: Deutsch Gewicht in Gramm: 222.

Gebundene Ausgabe. Etat : Gut. 112 Seiten Ausgabe von 1980, ausgesondertes BÃchereibuch 1409 Sprache: Deutsch Gewicht in Gramm: 222.

112 S. gute Erhaltung, Gebrauchsspuren , 0 Sprache: Deutsch Gewicht in Gramm: 450 20 cm, Gebunden , ohne Schutzumschlag .

Etat : Brand New. 151 pages. German language. 5.63x0.79x8.86 inches. In Stock.

hardcover. Etat : New.

Etat : Gut bis sehr gut. Bibliotheksbuch.

Etat : Leichte Gebrauchsspuren.

hardcover. Etat : New.

Etat : New. In.

Etat : New. In.

Taschenbuch. Etat : Gut. Orig.-Ausg., 1. Aufl. 112 S. Alle Bücher & Medienartikel von Book Broker sind stets in gutem & sehr gutem gebrauchsfähigen Zustand. Unser Produktfoto entspricht dem hier angebotenen Artikel, dieser weist folgende Merkmale auf: Helle/saubere Seiten in fester Bindung. Leichte Gebrauchsspuren. Sprache: Deutsch Gewicht in Gramm: 100.…

Etat : New. pp. xii + 117.

Hardcover. Etat : Gut. kA. Auflage. Anzahl Bände: 1 - Bd.Nr.: kA - Sprache: de - Einband: Hardcover - Gewicht: 203 - Illust.: kA - Zustand: Gut - Buch hat Lager- und Gebrauchsspuren, ggf. Stempel und Besitzeinträge. Aber vollständig, Bindung intakt, ohne häufige Anstreichungen o.ä. kA (illustrateur).…

Etat : Sehr gut. Zustand: Sehr gut | Sprache: Englisch | Produktart: Bücher | At the workshop held in Leverkusen on December 1, 1993, Professor Dr. Stanislav Kazda was honored on the occasion of his retirement for his scientific contributions and his involvement in drug development in our company, Bayer AG. In a recent article by Eugene Garfield (Current ContentslLife Sciences 36:3-15, 1993), what most of us participating in this workshop have supposed for years was confirmed: that Kazda is one of the leading scientific authors in academia worldwide. In the said survey of citations of biomedical research articles, Kazda is number 29 in terms of actual impact, individual ~itations, and total number of published manuscripts (and this only covers the time period from 1981 to 1992). In addition, his work has contributed significantly to the number eight ranking of our company in the so-called Corporation List. With the support of colleagues inside and outside the company, Kazda made a new substance class, the 1, 4-dihydropyridines, discovered by Bossert and Vater, well known to the scientific community on a worldwide basis and established its outstanding usefulness in hypertension. He has contributed numerous publi­ cations on the pharmacology of these calcium antagonists and organized several international conferences on the topic. Although he became famous as a cardiovascular pharmacologist, he started his career as a physician with the subjects obstetrics and gynecology. He studied at the Medical Faculty in Prague and at the Universities of Kasan and Kharkow (1950-1957). …

Etat : New. pp. xi + 119.

Paperback. Etat : Brand New. illustrated edition. 129 pages. 9.25x6.10x0.31 inches. In Stock.

Paperback. Etat : Brand New. 1st edition. 130 pages. 9.25x6.10x0.32 inches. In Stock.

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - At the workshop held in Leverkusen on December 1, 1993, Professor Dr. Stanislav Kazda was honored on the occasion of his retirement for his scientific contributions and his involvement in drug development in our company, Bayer AG. In a recent article by Eugene Garfield (Current ContentslLife Sciences 36:3-15, 1993), what most of us participating in this workshop have supposed for years was confirmed: that Kazda is one of the leading scientific authors in academia worldwide. In the said survey of citations of biomedical research articles, Kazda is number 29 in terms of actual impact, individual ~itations, and total number of published manuscripts (and this only covers the time period from 1981 to 1992). In addition, his work has contributed significantly to the number eight ranking of our company in the so-called Corporation List. With the support of colleagues inside and outside the company, Kazda made a new substance class, the 1, 4-dihydropyridines, discovered by Bossert and Vater, well known to the scientific community on a worldwide basis and established its outstanding usefulness in hypertension. He has contributed numerous publi cations on the pharmacology of these calcium antagonists and organized several international conferences on the topic. Although he became famous as a cardiovascular pharmacologist, he started his career as a physician with the subjects obstetrics and gynecology. He studied at the Medical Faculty in Prague and at the Universities of Kasan and Kharkow (1950-1957). …

Taschenbuch. Etat : Neu. Druck auf Anfrage Neuware - Printed after ordering - At the Pharmacology Workshop held in Wuppertal on December 11, 1992, Dr. Alexander Scriabine was honored for his contribution to drug develop ment at our company. Dr. Scriabine was the first pharmacologist to join Miles in West Haven, CT, in 1979. He established the Miles Institute for Preclinical Pharmacology, at the Yale campus, which was devoted to cardiovascular, metabolic and, 2 later, CNS research. At that time Ca + antagonists were not yet available in the USA, but well established in Europe. At Bayer, Bossert and Vater discovered 1,4-dihydropyridines in the late 1960s, and Fleckenstein identified 2 nifedipine as the most potent Ca + antagonist available at that time. This 2 discovery led to the establishment of Ca + antagonists as leading cardio vascular drugs throughout the world and to the marketing of nifedipine as Adalat by Bayer. The main function of the Miles Institute for Preclinical 2 Pharmacology was the introduction of Bayer Ca + antagonists to the American scientific community. Scriabine, in collaboration with Stanislav Kazda and Bernward Garthoff, contributed numerous publications on the 2 pharmacology of Bayer Ca + antagonists, supported many collaborative studies with extramural investigators in the USA, and organized several 2 international conferences on Ca + antagonists. These conferences contri buted to the recognition of the importance of these drugs for the treatment of hypertension and coronary heart disease in North America.…

Perfect Paperback. Etat : Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.

Hardcover. Etat : Wie neu. 112 Seiten Zustand: NEUWERTIGER Zustand! HC1-177-4/8-00778360 Sprache: Deutsch Gewicht in Gramm: 209.

Etat : Pappband. Oktav 1 Band 127 gut.

Softcover. 1985. 76 S. : Ill., graph. Darst., Kt. ; 24 cm Ungelesenes Buch im sehr guten Zustand. Leichte Lagerspuren. 9783531083384 Sprache: Deutsch Gewicht in Gramm: 168.

Hardback. Etat : New.

Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -At the workshop held in Leverkusen on December 1, 1993, Professor Dr. Stanislav Kazda was honored on the occasion of his retirement for his scientific contributions and his involvement in drug development in our company, Bayer AG. In a recent article by Eugene Garfield (Current ContentslLife Sciences 36:3-15, 1993), what most of us participating in this workshop have supposed for years was confirmed: that Kazda is one of the leading scientific authors in academia worldwide. In the said survey of citations of biomedical research articles, Kazda is number 29 in terms of actual impact, individual ~itations, and total number of published manuscripts (and this only covers the time period from 1981 to 1992). In addition, his work has contributed significantly to the number eight ranking of our company in the so-called Corporation List. With the support of colleagues inside and outside the company, Kazda made a new substance class, the 1, 4-dihydropyridines, discovered by Bossert and Vater, well known to the scientific community on a worldwide basis and established its outstanding usefulness in hypertension. He has contributed numerous publi cations on the pharmacology of these calcium antagonists and organized several international conferences on the topic. Although he became famous as a cardiovascular pharmacologist, he started his career as a physician with the subjects obstetrics and gynecology. He studied at the Medical Faculty in Prague and at the Universities of Kasan and Kharkow (1950-1957). 132 pp. Englisch.…